Changeflow GovPing Pharma & Life Sciences

Recent changes

Favicon for www.aifa.gov.it

PRAC Recommendations on Safety Signals

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has adopted recommendations on safety signals discussed in February 2026. These recommendations require marketing authorisation holders (MAHs) to provide supplementary information or take regulatory action, such as updating product information.

Priority review Guidance Pharmaceuticals
Favicon for www.aifa.gov.it

PRAC Recommendations on Signals - January 2026 Meeting

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has adopted recommendations on safety signals discussed in January 2026. Marketing Authorisation Holders (MAHs) for affected medicinal products are required to update product information within specified timelines.

Priority review Guidance Pharmaceuticals
Favicon for www.aifa.gov.it

PRAC Recommendations on Safety Signals

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has adopted recommendations on safety signals discussed in November 2025. Marketing Authorisation Holders (MAHs) are required to provide supplementary information or update product information based on these recommendations, with specific deadlines for certain signals.

Priority review Guidance Healthcare
Favicon for www.aifa.gov.it

PRAC Recommendations on Safety Signals

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has adopted recommendations on safety signals discussed in their October 2025 meeting. These recommendations are directly actionable by marketing authorisation holders (MAHs) for updates to product information.

Priority review Guidance Pharmaceuticals
Favicon for www.aifa.gov.it

PRAC Recommendations on Safety Signals

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has adopted recommendations on safety signals discussed between September 29 and October 2, 2025. These recommendations are directly actionable by marketing authorisation holders (MAHs) for both Centrally Authorised Products (CAPs) and Nationally Authorised Products (NAPs).

Priority review Notice Healthcare
Favicon for ansm.sante.fr

ArjoHuntleigh Tenor Mobile Hoist Safety Alert

The French National Agency for the Safety of Medicines and Health Products (ANSM) has announced a product recall for the ArjoHuntleigh Tenor mobile hoist. This action, registered under number R2606757, is being implemented by the manufacturer ArjoHuntleigh AB.

Priority review Notice Healthcare
Favicon for ansm.sante.fr

ANSM Safety Information: Mobile Hoist and Bath Elevator

The French National Agency for Medicines and Health Products Safety (ANSM) has issued safety information regarding a mobile hoist and bath elevator from Mangar International. This notice, registered under number R2607055, alerts home healthcare providers and retailers to a safety action implemented by the manufacturer.

Priority review Notice Healthcare
Favicon for ansm.sante.fr

Safety alert for DermaGenius 3.0 reagent

The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the DermaGenius 3.0 Complete Multiplex real-time PCR reagent. This alert, registered under number R2607183, informs medical biology analysis laboratories of a security action implemented by PathoNostics.

Priority review Notice Healthcare
Favicon for ansm.sante.fr

Spinal Plug Safety Alert for Pharmacies

The French ANSM has been informed of a lot recall action for spinal plugs (Airplug T10-T12) by Groupe Lépine, registered under action number R2607057. Pharmacies are directed to consult the provided letter from the manufacturer for details.

Priority review Notice Healthcare
Favicon for ansm.sante.fr

ANSM Safety Alert for Manosplint Cushionfoam Medical Device

The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the Manosplint Cushionfoam medical device, identified by safety action number R2606620. This alert concerns a safety action initiated by the manufacturer, Kinetec SAS.

Priority review Notice Healthcare

Showing 11–20 of 353 changes

1 2 3 4 36

57 monitored sources

Health Canada Recalls & Safety Alerts

Updated 4h ago 40 recent

FDA Warning Letters

Updated 19h ago 35 recent

MHRA Guidance & Safety

Updated 1d ago 20 recent

CPSC Product Recalls

Updated 18h ago 14 recent

FDA Guidance Documents

Updated 18h ago 12 recent

FDA Recalls & Safety Alerts

Updated 7h ago 11 recent

HHS OIG Reports & Publications

Updated 3d ago 9 recent

FDA MedWatch Safety Alerts

Updated 2d ago 8 recent

EMA News

Updated 8d ago 8 recent

HSA Singapore Announcements

Updated 10h ago 6 recent

NICE Technology Appraisals

Updated 1d ago 5 recent

USP Compendial Notices

Updated 1d ago 5 recent

NICE Highly Specialised Technology Evaluations

Updated 1d ago 5 recent

MHRA Drug Safety Update

Updated 1d ago 5 recent

ANSM France News

Updated 1d ago 5 recent

TGA Australia Safety Alerts

Updated 1d ago 5 recent

TGA Australia Media Releases

Updated 1d ago 5 recent

TX Board of Pharmacy News

Updated 1d ago 5 recent

PIC/S Publications & Updates

Updated 16h ago 5 recent

FDA Novel Drug Approvals

Updated 13h ago 5 recent

Canada Health Canada Drug Announcements

Updated 7h ago 5 recent

ANSM Drug & Device Safety Alerts

Updated 6h ago 5 recent

BfArM Drug Safety Communications

Updated 5h ago 5 recent

AIFA Drug Safety Signals

Updated 6h ago 5 recent

MA Pharmacy Practice Resources & Guidance

Updated 30d ago 5 recent

FDA CVM Veterinary Medicine Updates

Updated 1d ago 5 recent

FDA CBER Biologics Safety Communications

Updated 1d ago 5 recent

FDA CDRH Medical Devices News

Updated 1d ago 5 recent

CA Board of Pharmacy News

Updated 30d ago 5 recent

CT Commission of Pharmacy Meeting Minutes

Updated 30d ago 5 recent

VA Board of Pharmacy Newsletters

Updated 30d ago 5 recent

ECHA News

Updated 2d ago 5 recent

FDA Drug Recalls

Updated 1d ago 5 recent

EDQM Press Releases & News

Updated 15h ago 4 recent

NIH Policy Notices

Updated 13h ago 4 recent

WHO Pharmaceutical Standards

Updated 13h ago 4 recent

Swissmedic Health Professional Communications

Updated 1d ago 4 recent

FDA Clinical Trials Guidance

Updated 1d ago 4 recent

FDA Biosimilar Product Approvals

Updated 1d ago 4 recent

CMS Newsroom

Updated 1d ago 4 recent

FDA Drug Shortages

Updated 13h ago 3 recent

FDA Import Alerts

Updated 13d ago 3 recent

ICH Guidelines News

Updated 14h ago 3 recent

AMA Press Releases

Updated 14h ago 3 recent

MHRA Drug & Device Alerts

Updated 16h ago 3 recent

Health Canada InfoWatch

Updated 1d ago 3 recent

WHO News

Updated 1d ago 2 recent

PMDA Japan Drug Precaution Revisions

Updated 1d ago 2 recent

DEA Press Releases

Updated 13h ago 2 recent

FDA Medical Device Recalls

Updated 1d ago 2 recent

EMA CHMP Agendas & Minutes

Updated 1d ago 2 recent

DEA Public Safety Alerts

Updated 13h ago 1 recent

EMA News

Updated 13h ago 1 recent

MHRA Publications

Updated 1d ago 1 recent

TGA Australia Safety Alerts

Updated -- 0 recent

FDA Drug Safety Communications

Updated 1mo ago 0 recent

FDA Newly Added Guidance

Updated 1mo ago 0 recent

Need to monitor something else?

GovPing covers the common sources. For niche pages specific to your team, add custom URL monitoring with Changeflow.

Get Pharma & Life Sciences alerts

Daily digest of pharma & life sciences regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.